These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 200359)

  • 1. Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study.
    Baker LH; Saiki JH; Jones SE; Hewlett JS; Brownlee RW; Stephens RL; Vaitkevicius VK
    Cancer Treat Rep; 1977 Nov; 61(8):1595-7. PubMed ID: 200359
    [No Abstract]   [Full Text] [Related]  

  • 2. [Advanced hepatocellular carcinoma: value of systemic chemotherapy combining adriamycin, amiodarone and 5-fluorouracil].
    Bedenne L; Chauffert B; Lorcerie B; Faivre J; Hillon P; Klepping C; Martin F
    Gastroenterol Clin Biol; 1989 Oct; 13(10):845-6. PubMed ID: 2556316
    [No Abstract]   [Full Text] [Related]  

  • 3. Adriamycin therapy in American patients with hepatocellular carcinoma.
    Ihde DC; Kane RC; Cohen MH; McIntire KR; Minna JD
    Cancer Treat Rep; 1977 Oct; 61(7):1385-7. PubMed ID: 201380
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II evaluation of doxorubicin plus amiodarone in advanced hepatocarcinoma.
    Chauffert B; Seitz JF; Bedenne L; Renard P; Conroy T; Rougier P
    Gastroenterol Clin Biol; 1991; 15(10):774-5. PubMed ID: 1667769
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of a chemotherapeutic regimen for primary liver cancer in children.
    Senzer NN; Terrell W; Pratt CB
    Cancer Treat Rep; 1978 Sep; 62(9):1403-4. PubMed ID: 210945
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical studies in Asian patients with irresectible primary hepatocellular carcinoma treated by adriamycin and prednisolone alone or in combination with 5-fluorouracil, vincristine and prednisolone.
    Singapore Med J; 1978 Dec; 19(4):192-204. PubMed ID: 220733
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic results using VP 16-213 alone or in combination with 5-fluorouracil in liver cancer (hepatoma)].
    Cavalli F; Tschopp L; Gerber A; Sonntag RW; Ryssel HJ; Brunner KW
    Schweiz Med Wochenschr; 1977 Dec; 107(52):1960-6. PubMed ID: 202020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of hepatocellular carcinoma with adriamycin. Phase II clinical trial].
    Barbare JC; Ballet F; Petit J; Poupon R; Darnis F
    Gastroenterol Clin Biol; 1984; 8(8-9):679-80. PubMed ID: 6092187
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II trial of epirubicin in hepatoma.
    Shiu W; Mok SD; O SK; Tsao SY; Woo KS; Li A; Leung N; Martin C
    Cancer Treat Rep; 1986 Aug; 70(8):1035-6. PubMed ID: 3015405
    [No Abstract]   [Full Text] [Related]  

  • 10. Trial of adriamycin in primary hepatocellular carcinoma.
    Tsega E
    Ethiop Med J; 1984 Jan; 22(1):55-9. PubMed ID: 6317377
    [No Abstract]   [Full Text] [Related]  

  • 11. Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma.
    Schmidinger M; Wenzel C; Locker GJ; Muehlbacher F; Steininger R; Gnant M; Crevenna R; Budinsky AC
    Br J Cancer; 2001 Dec; 85(12):1850-2. PubMed ID: 11747325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy for hepatocellular cancer with intrahepatic arterial adriamycin and 5-fluorouracil combined with whole-liver irradiation: a Northern California Oncology Group Study.
    Friedman MA; Volberding PA; Cassidy MJ; Resser KJ; Wasserman TH; Phillips TL
    Cancer Treat Rep; 1979; 63(11-12):1885-8. PubMed ID: 230895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of bisantrene in hepatocellular carcinoma: a Southwest Oncology Group Study.
    Brown TD; Fleming TR; Shildt RA; Cowan JD
    Cancer Treat Rep; 1987 Nov; 71(11):1101-2. PubMed ID: 2824048
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of primary liver cancer: response to regional chemotherapy.
    Wellwood JM; Cady B; Oberfield RA
    Clin Oncol; 1979 Mar; 5(1):25-31. PubMed ID: 217565
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary hepatocellular carcinoma in the eastern province of Saudi Arabia: treatment with combination chemotherapy using 5-fluorouracil, Adriamycin and mitomycin-C.
    Al-Idrissi HY; Ibrahim EM; Abdel Satir A; Satti MB; Al-Kasem S; Al-Qurain A
    Hepatogastroenterology; 1985 Feb; 32(1):8-10. PubMed ID: 2985480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adriamycin (NSC-123127) versus 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in the treatment of metastatic prostate cancer.
    Eagan RT; Hahn RG; Myers RP
    Cancer Treat Rep; 1976 Jan; 60(1):115-7. PubMed ID: 1000515
    [No Abstract]   [Full Text] [Related]  

  • 17. [Selective chemotherapy of hepatocellular carcinomas].
    Keppler D; Pausch J; Gerok W
    Verh Dtsch Ges Inn Med; 1978; (84):606-10. PubMed ID: 217196
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of 5-FU and doxorubicin in the treatment of carcinoma of the bladder.
    Knight EW; Pagand M; Hahn RG; Horton J
    Cancer Treat Rep; 1983 May; 67(5):514-5. PubMed ID: 6850669
    [No Abstract]   [Full Text] [Related]  

  • 19. Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center.
    Abrams RA; Pajak TF; Haulk TL; Flam M; Asbell SO
    Cancer J Sci Am; 1998; 4(3):178-84. PubMed ID: 9612600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Should one treat with systemic adriamycin inoperable hepatocellular cancer in cirrhosis?].
    Ballet F; Barbare JC; Petit J; Poupon R; Darnis F
    Gastroenterol Clin Biol; 1982 Mar; 6(3):267-71. PubMed ID: 6284580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.